Contact
Contact

WARD EU

Back to projects

WARD EU

Principal Investigator

Sharri Junadi Mortensen, MD

Study design
Mixed-methods observational implementation study
Sample size
Four european countries including Denmark, The Netherlands, Portugal and Poland. Phase 1: 400 patients 120 nurses 100 patients and 30 nurses per country. Phase 2: 400 in-hospital patients, up to 200 home-monitored patients, up to 150 patients and 30 nurses per country
Inclusion criteria
  • Adults aged 18 years or older
  • Admitted with a medical or surgical condition
  • Expected hospital stay of at least two days
Study procedures
  • Informed consent
  • Observational data collection
  • Pre- and post-implementation questionnaires for patients and healthcare professionals
  • Patients wear clinical monitoring sensors
  • Nurses use WARD-CSS device/app for continuous vital-sign monitoring
  • Clinical outcomes and healthcare resource use are recorded
  • Follow-up up to 30 days after admission
Outcome
  • Phase 1:
    • Primary outcome: Map current monitoring practices
    • Secondary outcome: Patient experience
  • Phase 2:
    • Primary outcomes: Implementation potential and usability
    • Secondary outcomes: Adoption factors, data feasibility, complications ≤30 days
Trial registration
NCT07451249

–  Read more

Menu
Contact